期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

阿托伐他汀对脑梗死患者血脂及高敏C反应蛋白的影响

原文传递
导出
摘要 目的探讨阿托伐他汀对脑梗死患者血脂及高敏C反应蛋白(hs-CRP)值的影响。方法选取38例脑梗死合并高脂血症的患者,随机分为2个组,即阿托伐他汀组(20例)和辛伐他汀(18例)组,观察患者用药前后血脂及hs-CRP的变化。结果患者在用药4周后,阿托伐他汀组和辛伐他汀组血清中甘油三酯、总胆固醇、低密度脂蛋白均显著降低(P<0.05),差异有统计学意义;阿托伐他汀组和辛伐他汀组hs-CRP均显著降低(P<0.05),但阿托伐他汀组降低更为明显(P<0.05)。结论阿托伐他汀可在短时间内降低脑梗死患者的血脂及hs-CRP值,从而降低脑血管疾病的发生。
作者 吴瑾 吴玉彬
机构地区 河南省职工医院神经内科
出处 《医药论坛杂志》 2010年第24期131-132,共2页 Journal of Medical Forum
关键词 脑梗塞 高敏C反应蛋白 阿托伐他汀
分类号 R743.33 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献7

  • 1金凤表,侯瑞田,蒋宝琦,吴彦.阿托伐他汀的非调脂作用[J].心血管病学进展,2003,24(2):125-127. 被引量：22
  • 2Rifai N, Ridker PM. Proposed cardiovascular risk as- sessment algorithm using high - sensitivity C - reactive protein and lipid screening [ J ]. Clin Chem, 2001 , 47 ( 1 ) :28-30.
  • 3Blanco - Colio LM, Tunon J, Martin - Ventural, et al. Anti - inflammatory and immunomodulatory effects of statins[ J]. Kidney lnt,2003,63 ( 1 ) : 12-23.
  • 4Kent SM, Flaherty PJ, Coyle IC, et al. Effect of atorvastatin and pravastatin on serum C - reactive protein [ J ]. Am Heart J,2003,145(2) :8-9.
  • 5Gratsianskii NA. Statins as Anti - Inflammatory Agents [ J]. Kardiologiia,2001,41 (12) : 14-26.
  • 6Ridker PM. Rapid reduction in C - reactive protein with cerivastatin among 785 patients with primany hyperchol- esterolemia [ J ]. Circulation, 2001,103 ( 4 ) : 1191 - 1193.
  • 7mulvihill NT, Foley JB. Inflammation in acute coronary syndromes [ J ]. Heart,2002,87 ( 3 ) :201-204.

二级参考文献13

  • 1[1]Wilcox LJ, Barrett PH, Huff MW. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin[J]. J Lipid Res, 1999,40(6) :1078-1089.
  • 2[2]Elkin RG, Yan Z ,Zhong Y, et al. Select 3-hydroxy-3-methylglutary 1-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition[J].J Nutr, 1999,129(5) :1010-1019.
  • 3[3]Alfon J, Guasch JF, Berrozpe M,et al. Nitric oxide synthase Ⅱ(NOS Ⅱ ) gene expreuion correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors[J]. Atherosclerosis, 1999,145 (2) :325 -331.
  • 4[4]Wagner AH, Kohler T, Ruckschloss U,et al. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial auperoxide anion formation [J]. Arterioscler Thromb Vasc Biol,2000,20( 1 ) :61-69.
  • 5[5]Bustos C, Hernandez-Presa MA, Orteqo M,et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis[ J ]. J Am Coll Cardiol, 1998,32 (7) :2057-2064.
  • 6[6]Park HJ, Galper JB. 3-Hydroxy-3-methylglutary1 CoA reductase inhibitors upregulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc Natl Acad Sci USA [ J ].1999,96(20) :11525-11530.
  • 7[7]Strandberg TE,Vanhanen H, Tikkanen MJ. Effect of statins on C-reactive protein in patients with coronary heart disease[J]. Lancet, 1999,353:118-119.
  • 8[8]Tesfamariam B, Frohlich BH, Gregg RE. Differential effects of pravastatin,simvastatin, and atorvastatin on Ca2 + release and vascular reactivity[J]. J Cardiovasc Pharmacol, 1999,34( 1 ) :95-101.
  • 9[9]Niekenig G, Baumer AT, Temur Y, et al. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men[J].Circulation. 1999.100(21 ) :2131-2134.
  • 10[10]Alfon J, Pueyo Palazon C, Royo T,et al. Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model[J]. Thromb Haemost,1999,81 (5) :822-827.

共引文献21

医药论坛杂志
2010年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部